Simply Wall St.
Is UPLIZNA’s EU Approval Reframing Amgen’s Rare Disease Strategy And Investment Case (AMGN)?
📊
AI Sentiment
Positive
7/10
Amgen Inc. News
Latest updates and market news for AMGN
20 news
Feb 9 - Feb 15, 2026
Page 1
MarketBeat
InflaRx Spotlights Izicopan HS Data, Phase 2b Plans and 30% Cost Cuts at Guggenheim Summit
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
📊
AI Sentiment
Positive
7/10
Insider Monkey
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN)
📈
AI Sentiment
Highly Positive
9/10
MarketBeat
Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52
📈
AI Sentiment
Highly Positive
8/10
Clinical Trials Arena
Upstream Bio’s stock drops 47% on verekitug Phase II asthma data
📉
AI Sentiment
Negative
2/10
Investor's Business Daily
Upstream Bio Crashes After Asthma Drug Succeeds — With The Wrong Dose
📉
AI Sentiment
Negative
3/10
GlobeNewswire
Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend
📊
AI Sentiment
Positive
6/10
MT Newswires
Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating
📊
AI Sentiment
Positive
7/10
StockStory
The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
Stock Market Today: Dow Up As Oracle Soars; Cathie Wood Buys Buffett Stock Amid 145% Run (Live Coverage)
📊
AI Sentiment
Positive
7/10
Zacks
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
📊
AI Sentiment
Positive
6/10
Insider Monkey
CVS Health Corporation (CVS) Under Pressure From Medicare Proposal, Argus Holds Positive View
📊
AI Sentiment
Positive
7/10
Share this news page